Prediction of methicillin-resistant Staphylococcus aureusin patients with non-nosocomial pneumonia

BMC Infectious Diseases

Table 5 Treatment and clinical outcomes of pneumonia patients with MRSA and non-MRSA ^a

Treatment and clinical outcomes	MRSA	Non-MRSA	P-value
Treatment and clinical outcomes	(n=78)	(n=865)	P-value
Treatment
Intubation in ER	11 (14.1)	94 (10.9)	0.384
Intubation in overall	18 (23.1)	185 (21.4)	0.728
ICU admission via ER	11 (14.1)	152 (17.6)	0.438
ICU admission in overall	22 (28.2)	212 (24.5)	0.469
Clinical outcomes
In-hospital mortality	26 (33.3)	186 (21.5)	0.017
Days of ICU stay, median(IQR)	15.5 (11–30)^b	10 (3–20)^c	0.057
Days of hospital stay, median(IQR)	16.5 (10–30)	11 (6–20)	0.001

^aData are presented as numbers (percentages) unless otherwise indicated.
^bn = 22.
^cn = 212.
Abbreviations: MRSA methicillin resistant Staphylococcus aureus, ER emergency room, IQR interquartile range, ICU intensive care unit.

ISSN: 1471-2334